A lesson in how not to roll out real-time CGM to an existing system
What impact does a botched rollout of an app update have on a CGM provider?
Abbott Freestyle Libre
The art of CGM accuracy studies, part 2: The Freestyle Libre3
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
If COVID vaccines were deployed in England like Diabetes medication, many would be waiting for them in 2025…
As a headline, this seems like a harsh statement to make. As an observation of the organisation and effectiveness of England’s healthcare model, perhaps less […]
Abbott Freestyle Libre 3 – here already?
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
Diabetes tech or not diabetes tech? “Libre Sense” is the question…
Whilst that’s a very poor nod to Shakespeare, Libre Sense is the question here. And that’s because they announced the launch of a “Glucose Sport […]
High temperatures, extreme conditions and glucose sensors… an n=1 observation
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
Libre Accuracy and Calibration using a third party transmitter – a case study
Abstract Introduction As a result of increased use of third party add-on transmitters to the Libre system to convert them into CGM, and the use […]
Libre with MiaoMiao – calibration and comparison
Following the release of the FDA statement about DIY systems, and the implication that it is a DIY CGM that caused the issue (essentially Libre […]
#FreestyleLibre & #MiaoMiao: Two weeks. What did I think?
After running with the FreeStyle Libre with the MiaoMiao as a CGM system for two weeks, I’ve drawn some conclusions from use, although there’s a […]
Death or profit: Flash, CGM and patient-centricity
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]